Related Experiment Video
Updated: Jul 4, 2026

The bm12 Inducible Model of Systemic Lupus Erythematosus (SLE) in C57BL/6 Mice
Published on: November 1, 2015
Severe systemic lupus erythematosus induced by antiviral treatment for hepatitis C
Vincent Ho1, Anna Mclean, Shaughan Terry
1School of Medicine, James Cook University, Queensland, Australia. Vincent_ho@health.qld.gov.au
Abstract:
We report the case of a 43-year-old man who developed systemic lupus erythematosus (SLE) after receiving pegylated alpha-interferon and ribavirin for chronic hepatitis C. He displayed 8 features of the American College of Rheumatology criteria for SLE: glomerulonephritis, arthritis, serositis, a florid discoid rash, lymphopenia, oral ulcers, the development of high titers of antinuclear antibodies, and antidouble stranded DNA antibodies. Furthermore, his admission was complicated by the development of life threatening myopericarditis and vasculitis. This case is notable for the clinical severity and nature of multiorgan lupus involvement from hepatitis C antiviral therapy. Clinical signs of SLE have resolved and anti DS DNA has normalized.
Related Concept Videos
Hepatitis
Viral Hepatitis I: Introduction
Cytomegalovirus Disease
Inhibitors of Viral Protein Synthesis
Antiviral Nucleoside Inhibitors
Nephrotic Syndrome II : Assessment and Medical Management
